1. 194P Thermal ablation followed by intratumoral injection of a novel immune stimulant IP-001 in patients with advanced solid tumors: Phase IB part of study SAKK 66/17. (December 2022) Authors: Joerger, M.; Knüsel, P.; Alejandre-Lafont, E.; Metaxas, Y.; Mark, M.T.; von Moos, R.A.F.; Gysel, K.; Eckhardt, K.; Glaus Garzon, J.; Koster, K-L.; Wittwer, Y.; Tissot, S.; Flatz, L.; Alleruzzo, L.; Lam, S.K.; Anderson, D.; Chen, W.; Baskin-Bey, E.; Hode, T. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗